Detalhe da pesquisa
1.
Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.
Circulation
; 138(8): 770-781, 2018 08 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29618599
2.
Bridging the "Know-Do" Gaps in Five Non-Communicable Diseases Using a Common Framework Driven by Implementation Science.
J Healthc Leadersh
; 15: 103-119, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37416849
3.
TRS2P and LDL-C alone or in combination for predicting absolute benefits from additional LDL-C lowering: Analysis from the TNT trial.
Atherosclerosis
; 322: 8-14, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33706084
4.
Atorvastatin Has a Dose-Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double-Blind Randomized Controlled Trials.
J Am Heart Assoc
; 8(9): e010827, 2019 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31020900
5.
Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.
J Clin Lipidol
; 12(2): 356-366, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29310989
6.
Relationship of High-Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin.
J Am Heart Assoc
; 7(2)2018 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29358194